ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.446,25
0,91%
S&P 500
5.461,03
-0,07%
US Dollar vs BRL
5,3915
-1,06%
Bitcoin
61.221,30
-3,07%
Brent Oil
84,655
0,76%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Magenta Therapeutics Inc (MGTA)

  7. Magenta Therapeutics Inc (MGTA) Notícias

MGTA

Magenta Therapeutics (MGTA)

Magenta Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:MGTA
DataHoraFonteTítuloCódigoCompanhia
06/06/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
28/05/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
28/05/202418:24Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MGTAMagenta Therapeutics Inc
09/05/202417:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGTAMagenta Therapeutics Inc
11/04/202417:10Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MGTAMagenta Therapeutics Inc
11/04/202417:09Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MGTAMagenta Therapeutics Inc
11/04/202417:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MGTAMagenta Therapeutics Inc
01/04/202419:34Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
28/03/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MGTAMagenta Therapeutics Inc
21/03/202418:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MGTAMagenta Therapeutics Inc
21/03/202418:02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
21/03/202417:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MGTAMagenta Therapeutics Inc
14/02/202418:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
02/02/202418:32Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MGTAMagenta Therapeutics Inc
31/01/202414:11Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:MGTAMagenta Therapeutics Inc
04/10/202317:20Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MGTAMagenta Therapeutics Inc
20/09/202322:50Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
13/09/202322:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
31/08/202310:00Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:MGTAMagenta Therapeutics Inc
17/07/202310:30Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
22/06/202318:25Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:MGTAMagenta Therapeutics Inc
19/05/202317:28Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MGTAMagenta Therapeutics Inc
19/05/202317:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MGTAMagenta Therapeutics Inc
15/05/202318:03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MGTAMagenta Therapeutics Inc
15/05/202317:13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MGTAMagenta Therapeutics Inc
15/05/202309:43Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:MGTAMagenta Therapeutics Inc
03/05/202309:00Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:MGTAMagenta Therapeutics Inc
03/05/202308:00GlobeNewswire Inc.Magenta Therapeutics and Dianthus Therapeutics Announce Merger AgreementNASDAQ:MGTAMagenta Therapeutics Inc
01/05/202309:31Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:MGTAMagenta Therapeutics Inc
31/03/202317:10GlobeNewswire Inc.Magenta Therapeutics Adopts Limited Duration Stockholder Rights PlanNASDAQ:MGTAMagenta Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:MGTA

Seu Histórico Recente

BIT
NSCIT8785JL3
European Investment Bank...
TG
BL43
Bridgeline Digital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados